'Flu' and structure-based drug design (Q41613210)

5 October 2017

1 reference

title

'Flu' and structure-based drug design (English)

1 reference

5 October 2017

Wade RC

1

1 reference

5 October 2017

1 September 1997

1 reference

5 October 2017

1 reference

5 October 2017

5

1 reference

5 October 2017

1139-1145

1 reference

5 October 2017

9

1 reference

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

5 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Neuraminidase inhibitors as potential anti-influenza drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Influenza virus neuraminidase: structure, antibodies, and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

The inhibition of neuraminidase and antiviral action

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 2. Ligand probe groups with the ability to form more than two hydrogen bonds

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Structures of aromatic inhibitors of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Guanidinobenzoic acid inhibitors of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

CLIX: A search algorithm for finding novel ligands capable of binding proteins of known three‐dimensional structure

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Use of sialic acid analogues to define functional groups involved in binding to the influenza virus hemagglutinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

Optically controlled collisions of biological objects to evaluate potent polyvalent inhibitors of virus-cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900265-7

7 January 2021

10.1016/S0969-2126(97)00265-7

Identifiers

DOI

1 reference

5 October 2017

1 reference

PubMed ID

9331424